Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Venn Life Sciences Holdings PLC Establishes Joint Venture in Russia


Thursday, 7 Feb 2013 02:00am EST 

Venn Life Sciences Holdings PLC announced its expansion into Russia through the establishment of Venn Russia, a new joint venture with a locally established CRO. Venn Russia, which will operate from offices in Moscow. Venn Russia complements the existing European CRO business with their on-the-ground knowledge of local regulatory standards, investigator relationships and multilingual staff. 

Company Quote

20.25
0.0 +0.00%
1 Jul 2014